Tammemägi, Martin C. http://orcid.org/0000-0002-4989-5058
Darling, Gail E.
Schmidt, Heidi
Walker, Meghan J.
Langer, Deanna
Leung, Yvonne W.
Nguyen, Kathy
Miller, Beth
Llovet, Diego http://orcid.org/0000-0002-6911-5143
Evans, William K.
Buchanan, Daniel N. http://orcid.org/0000-0001-6589-8606
Espino-Hernandez, Gabriela
Aslam, Usman
Sheppard, Amanda
Lofters, Aisha
McInnis, Micheal http://orcid.org/0000-0002-5725-3258
Dobranowski, Julian
Habbous, Steven http://orcid.org/0000-0002-9650-9105
Finley, Christian
Luettschwager, Marianne
Cameron, Erin
Bravo, Caroline http://orcid.org/0000-0003-3941-705X
Banaszewska, Anna
Creighton-Taylor, Katherin
Fernandes, Brenda
Gao, Julia
Lee, Alex
Lee, Van
Pylypenko, Bogdan
Yu, Monica
Svara, Erin
Kaushal, Shivali
MacNiven, Lynda
McGarry, Caitlin
Della Mora, Lauren
Koen, Liz
Moffatt, Jessica
Rey, Michelle
Yurcan, Marta
Bourne, Laurie
Bromfield, Gillian http://orcid.org/0009-0009-8916-9462
Coulson, Melissa
Truscott, Rebecca
Rabeneck, Linda
Article History
Received: 4 August 2023
Accepted: 1 March 2024
First Online: 19 April 2024
Competing interests
: None of the authors had competing interests except for M.C.T. M.C.T. developed the PLCOm2012noRace lung cancer risk prediction model, which is used in the Pilot. The model is open access and is available free of charge to non-commercial users. For commercial users, licensing has been assigned to Brock University. To date, M.C.T. has not received any money for use of the PLCOm2012 model nor does he anticipate any payments in the future.